We are international
Donate
TEXT SIZE   


Module 3: Post-Treatment Maintenance, Relapsed or Refractory Disease, and Other Issues
08.09.02

Module 3: Post-Treatment Maintenance, Relapsed or Refractory Disease, and Other Issues Related to Multiple Myeloma

Release Date: August 2002
Expiration Date: August 31, 2003

Program Overview

Post-Treatment Maintenance, Relapsed or Refractory Disease, and Other Issues Related to Multiple Myeloma describes the options available to patients needing maintenance therapy, those who have relapsed or refractory disease, and the management of treatment side effects.

Learning Objectives

After completing Module 3, participants should be able to do the following:

  1. Discuss the indications for maintenance, relapse, and refractory treatments for multiple myeloma.
  2. Recognize the risks and benefits of second transplants.
  3. Distinguish between treatment for "cure" and treatment for palliation.
  4. Describe the different complications of myeloma and treatments for the disease.

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Institute for Continuing Healthcare Education and the International Myeloma Foundation. The Institute for Continuing Healthcare Education is accredited by the ACCME to provide continuing medical education for physicians.

The Institute for Continuing Healthcare Education designates this activity for a maximum of 1.75 hours in category 1 credit toward the AMA Physician s Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity.

Begin Activity


 related articles